Zenas BioPharma, Inc. (ZBIO) Net margin 2023–2025
Zenas BioPharma, Inc. (ZBIO) net profit margin by fiscal year — reported net income divided by reported revenue.
-3777.4%FY2025 · since FY2023: -74.2% → -3777.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -3777.4% | -637.6 pp |
| FY2024 | -3139.8% | -3065.5 pp |
| FY2023 | -74.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ZBIO financial trends
ZBIO RevenueZBIO Net incomeZBIO Gross profitZBIO Gross marginZBIO Operating incomeZBIO Operating marginZBIO Operating cash flowZBIO Free cash flowZBIO Capital expendituresZBIO Return on equityZBIO Stock buybacksZBIO Dividends paidZBIO Total assetsZBIO Total liabilitiesZBIO Shareholders’ equityZBIO overview →